Healthcare
Veterinary Pharmaceuticals • Regulated Manufacturing Facilities
Location: MENA Region
Indicative Investment Size: USD 12–15 million
Indicative Financing Coverage: Approximately 80% (subject to approvals)
Disclosure: This case study describes an advisory engagement. Al Taiff acted in a financial advisory and coordination capacity and did not act as a lender, contractor, arranger in a regulated capacity, or guarantor. All figures are indicative and subject to third-party approvals, documentation, regulatory requirements, and applicable laws.
The Situation
The healthcare and veterinary sector requires precision, strict regulatory compliance, and financing structures that align with manufacturing and quality standards. A sponsor planned the establishment of a veterinary pharmaceutical manufacturing facility to serve domestic demand and prepare for future exports but required feasibility validation, capital structuring, and coordinated execution planning.
Advisory Scope
Al Taiff provided financial advisory and coordination support, including:
- Preparation of a market-focused feasibility study assessing demand, compliance requirements, and commercial viability
- Advisory support in structuring a financing framework targeting USD 12–15 million, with indicative coverage of approximately 80%, subject to third-party approvals
- Coordination support for sourcing specialized equipment through international providers via Turkey, aligned with required manufacturing standards
- Planning and coordination inputs for installation and commissioning to support regulatory compliance and operational readiness
Outcome
The engagement resulted in a state-of-the-art veterinary pharmaceutical manufacturing facility positioned to supply domestic demand and support future export readiness. The project achieved stronger investment readiness, regulatory alignment, and operational preparedness.